Ultragenyx Pharma raises $121M in IPO

... is developing potential treatments for acute pain and heart failure. It will trade under the ticker symbol "TRVN." Shelton, Conn.-based Cara Therapeutics Inc. raised $55 million after pricing 5 million shares at $11 each. Cara focuses on pain ...



via Shelton Newswire http://ift.tt/MFIwXC